These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Small intestinal motor activity--its role in gut homeostasis and disease. Quigley EM Q J Med; 1987 Oct; 65(246):799-810. PubMed ID: 3329737 [TBL] [Abstract][Full Text] [Related]
31. Equine gastrointestinal motility research: where we are and where we need to go. Hudson NP; Merritt AM Equine Vet J; 2008 Jun; 40(4):422-8. PubMed ID: 18487107 [TBL] [Abstract][Full Text] [Related]
32. [On the possibility of using prokinetics in gastroenterology]. Sheptulin AA; Vize-Khripunova MA Klin Med (Mosk); 2010; 88(5):19-22. PubMed ID: 21089451 [TBL] [Abstract][Full Text] [Related]
34. Access options for withdrawn motility-modifying agents. Jones MP Am J Gastroenterol; 2002 Sep; 97(9):2184-8. PubMed ID: 12358230 [TBL] [Abstract][Full Text] [Related]
35. Esophageal motility abnormalities in cirrhotic patients before and after endoscopic variceal treatment. Fass R; Landau O; Kovacs TO; Ippoliti AF Am J Gastroenterol; 1997 Jun; 92(6):941-6. PubMed ID: 9177506 [TBL] [Abstract][Full Text] [Related]
36. Neural control of the gastrointestinal tract: implications for Parkinson disease. Cersosimo MG; Benarroch EE Mov Disord; 2008 Jun; 23(8):1065-75. PubMed ID: 18442139 [TBL] [Abstract][Full Text] [Related]
37. Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders. Sanger GJ; Lee K Nat Rev Drug Discov; 2008 Mar; 7(3):241-54. PubMed ID: 18309313 [TBL] [Abstract][Full Text] [Related]
38. Tachykinin receptors as drug targets for motility disorders. Hoogerwerf WA; Sarna SK Dig Dis; 2006; 24(1-2):83-90. PubMed ID: 16699266 [TBL] [Abstract][Full Text] [Related]
39. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders. Peeters TL Curr Opin Pharmacol; 2006 Dec; 6(6):553-8. PubMed ID: 17011824 [TBL] [Abstract][Full Text] [Related]